US Stock MarketDetailed Quotes

Atossa Therapeutics (ATOS)

Watchlist
  • 0.6308
  • -0.0238-3.64%
Trading Jan 23 09:39 ET
81.48MMarket Cap-2.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atossa Therapeutics (ATOS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-26.42%-6.01M
-60.21%-7.26M
-26.84%-5.96M
-0.43%-21.03M
-26.57%-7.05M
-22.33%-4.75M
-1.48%-4.53M
33.10%-4.7M
-0.87%-20.94M
-23.17%-5.57M
Net income from continuing operations
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
15.25%-25.5M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-11.62%-30.09M
-3.51%-7.75M
Operating gains losses
----
----
----
--7K
--4K
---1K
--2K
--2K
----
----
Depreciation and amortization
0.00%4K
0.00%4K
-20.00%4K
-26.09%17K
-71.43%4K
33.33%4K
33.33%4K
66.67%5K
187.50%23K
600.00%14K
Change In working capital
10,450.00%1.9M
-68.62%364K
-74.60%192K
-70.51%448K
-190.06%-1.49M
-98.73%18K
50.85%1.16M
132.63%756K
353.59%1.52M
16.12%1.65M
-Change in prepaid assets
640.52%827K
-214.29%-1.03M
-138.40%-255K
-89.12%386K
-623.94%-1.03M
-105.11%-153K
132.73%903K
116.99%664K
227.95%3.55M
7.79%-142K
-Change in payables and accrued expense
348.97%1.31M
947.50%1.26M
27.35%1.36M
91.94%-181K
-728.50%-1.66M
89.61%292K
151.72%120K
154.09%1.06M
-206.75%-2.25M
-108.87%-200K
-Change in other current assets
-563.38%-329K
100.90%1K
---11K
119.51%331K
--371K
104.18%71K
-11,000.00%-111K
--0
-184.25%-1.7M
--0
-Change in other current liabilities
106.05%19K
181.25%26K
0.00%23K
-116.59%-296K
-98.48%27K
-1,156.00%-314K
-68.42%-32K
-50.00%23K
89,300.00%1.78M
22,375.00%1.78M
-Change in other working capital
-41.80%71K
-60.00%112K
7.54%-920K
61.24%208K
281.43%801K
1,209.09%122K
-55.77%280K
-41.54%-995K
-62.17%129K
-53.74%210K
Cash from discontinued investing activities
Operating cash flow
-26.42%-6.01M
-60.21%-7.26M
-26.84%-5.96M
-0.43%-21.03M
-26.57%-7.05M
-22.33%-4.75M
-1.48%-4.53M
33.10%-4.7M
-0.87%-20.94M
-23.17%-5.57M
Investing cash flow
Cash flow from continuing investing activities
30.00%-7K
0
-50.00%-9K
-35.71%-19K
0
-900.00%-10K
76.92%-3K
-6K
99.70%-14K
0
Net PPE purchase and sale
30.00%-7K
--0
-50.00%-9K
-35.71%-19K
--0
-900.00%-10K
76.92%-3K
---6K
48.15%-14K
--0
Cash from discontinued investing activities
Investing cash flow
30.00%-7K
--0
-50.00%-9K
-35.71%-19K
--0
-900.00%-10K
76.92%-3K
---6K
99.70%-14K
--0
Financing cash flow
Cash flow from continuing financing activities
0
0
0
349.02%3.67M
3.37M
0
100K
204K
-1.48M
0
Net common stock issuance
----
----
----
--0
--0
----
----
----
---1.48M
--0
Proceeds from stock option exercised by employees
--0
--0
--0
--3.67M
--3.37M
--0
--100K
--204K
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
349.02%3.67M
--3.37M
--0
--100K
--204K
---1.48M
--0
Net cash flow
Beginning cash position
-27.21%57.97M
-22.41%65.23M
-19.62%71.19M
-20.21%88.57M
-20.46%74.88M
-19.96%79.64M
-19.15%84.07M
-20.21%88.57M
-18.67%111M
-19.86%94.14M
Current changes in cash
-26.30%-6.01M
-63.71%-7.26M
-32.62%-5.97M
22.53%-17.38M
33.91%-3.68M
11.18%-4.76M
0.98%-4.43M
35.92%-4.5M
11.99%-22.43M
14.70%-5.57M
End cash Position
-30.61%51.96M
-27.21%57.97M
-22.41%65.23M
-19.62%71.19M
-19.62%71.19M
-20.46%74.88M
-19.96%79.64M
-19.15%84.07M
-20.21%88.57M
-20.21%88.57M
Free cash flow
-26.30%-6.01M
-60.10%-7.26M
-26.87%-5.97M
-0.45%-21.05M
-26.57%-7.05M
-22.55%-4.76M
-1.25%-4.53M
33.01%-4.7M
-0.81%-20.96M
-22.95%-5.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -26.42%-6.01M-60.21%-7.26M-26.84%-5.96M-0.43%-21.03M-26.57%-7.05M-22.33%-4.75M-1.48%-4.53M33.10%-4.7M-0.87%-20.94M-23.17%-5.57M
Net income from continuing operations -20.22%-8.69M-39.25%-8.42M-14.29%-6.72M15.25%-25.5M18.15%-6.35M-16.07%-7.23M38.46%-6.05M6.42%-5.88M-11.62%-30.09M-3.51%-7.75M
Operating gains losses --------------7K--4K---1K--2K--2K--------
Depreciation and amortization 0.00%4K0.00%4K-20.00%4K-26.09%17K-71.43%4K33.33%4K33.33%4K66.67%5K187.50%23K600.00%14K
Change In working capital 10,450.00%1.9M-68.62%364K-74.60%192K-70.51%448K-190.06%-1.49M-98.73%18K50.85%1.16M132.63%756K353.59%1.52M16.12%1.65M
-Change in prepaid assets 640.52%827K-214.29%-1.03M-138.40%-255K-89.12%386K-623.94%-1.03M-105.11%-153K132.73%903K116.99%664K227.95%3.55M7.79%-142K
-Change in payables and accrued expense 348.97%1.31M947.50%1.26M27.35%1.36M91.94%-181K-728.50%-1.66M89.61%292K151.72%120K154.09%1.06M-206.75%-2.25M-108.87%-200K
-Change in other current assets -563.38%-329K100.90%1K---11K119.51%331K--371K104.18%71K-11,000.00%-111K--0-184.25%-1.7M--0
-Change in other current liabilities 106.05%19K181.25%26K0.00%23K-116.59%-296K-98.48%27K-1,156.00%-314K-68.42%-32K-50.00%23K89,300.00%1.78M22,375.00%1.78M
-Change in other working capital -41.80%71K-60.00%112K7.54%-920K61.24%208K281.43%801K1,209.09%122K-55.77%280K-41.54%-995K-62.17%129K-53.74%210K
Cash from discontinued investing activities
Operating cash flow -26.42%-6.01M-60.21%-7.26M-26.84%-5.96M-0.43%-21.03M-26.57%-7.05M-22.33%-4.75M-1.48%-4.53M33.10%-4.7M-0.87%-20.94M-23.17%-5.57M
Investing cash flow
Cash flow from continuing investing activities 30.00%-7K0-50.00%-9K-35.71%-19K0-900.00%-10K76.92%-3K-6K99.70%-14K0
Net PPE purchase and sale 30.00%-7K--0-50.00%-9K-35.71%-19K--0-900.00%-10K76.92%-3K---6K48.15%-14K--0
Cash from discontinued investing activities
Investing cash flow 30.00%-7K--0-50.00%-9K-35.71%-19K--0-900.00%-10K76.92%-3K---6K99.70%-14K--0
Financing cash flow
Cash flow from continuing financing activities 000349.02%3.67M3.37M0100K204K-1.48M0
Net common stock issuance --------------0--0---------------1.48M--0
Proceeds from stock option exercised by employees --0--0--0--3.67M--3.37M--0--100K--204K--0--0
Cash from discontinued financing activities
Financing cash flow --0--0--0349.02%3.67M--3.37M--0--100K--204K---1.48M--0
Net cash flow
Beginning cash position -27.21%57.97M-22.41%65.23M-19.62%71.19M-20.21%88.57M-20.46%74.88M-19.96%79.64M-19.15%84.07M-20.21%88.57M-18.67%111M-19.86%94.14M
Current changes in cash -26.30%-6.01M-63.71%-7.26M-32.62%-5.97M22.53%-17.38M33.91%-3.68M11.18%-4.76M0.98%-4.43M35.92%-4.5M11.99%-22.43M14.70%-5.57M
End cash Position -30.61%51.96M-27.21%57.97M-22.41%65.23M-19.62%71.19M-19.62%71.19M-20.46%74.88M-19.96%79.64M-19.15%84.07M-20.21%88.57M-20.21%88.57M
Free cash flow -26.30%-6.01M-60.10%-7.26M-26.87%-5.97M-0.45%-21.05M-26.57%-7.05M-22.55%-4.76M-1.25%-4.53M33.01%-4.7M-0.81%-20.96M-22.95%-5.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.50%
Sample Name
Sample Code
 +1.21%
Sample Name
Sample Code
 +1.19%
4
Salesforce
CRM
+1.14%
5
Netflix
NFLX
+1.13%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.07%
Sample Name
Sample Code
 +8.01%
Sample Name
Sample Code
 +4.16%
4
H World Group
HTHT
+4.08%
5
New Oriental
EDU
+3.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -